Financial Services Industry
Industry: Email Alert RSS FeedPhytopharm Begins Level-I Program
Global Finance, Oct 2004
Cambridge, UK-based Phytopharm, which develops plant-based medicines and manufactures them to pharmaceutical standards, established a Level-I ADR program with Bank of New York as depositary.
The Level-I program is the first step toward listing Phytopharm's securities on Nasdaq, according to the company, which has hired Global Markets Capital Group to manage the listing process.
Phytopharm CEO Richard Dixey says US investors are interested in the company's products for obesity, Alzheimer's disease and Lou Gehrig's disease.
Most PopularCBS MoneyWatch.com Articles
Each Phytopharm ADR represents two ordinary shares, which are traded on the London Stock Exchange.
- How to choose the right insurance carrier for your business
- Real Estate: Prepare your properties to weather what lies ahead
- Technology: Be prepared if part of your global supply chain goes missing
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Design a commission plan that drives sales - Sales Commissions


